JADE101 for proteinuria

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 21 Apr 2026: Trial registered, NCT07541287
  2. 19 May 2026: Trial started, NCT07541287

The trials

NCT07541287: A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

State
Under way
Phase
Phase 2
People
30 planned
Started
19 May 2026
Primary completion
Jan 2029
Arms
JADE101
Results
None posted
  1. 21 Apr 2026: Trial registered
  2. 19 May 2026: Trial started

NCT07902817: A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy

State
Under way
Phase
Phase 3
People
480 planned
Started
Dec 2026
Primary completion
Jun 2029
Arms
JADE101 Q8W, JADE101 Q12W
Results
None posted
  1. 29 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.